Church & Dwight
CHD
$97.16
+0.83%
Church & Dwight is a leading global producer of baking soda and a diversified consumer packaged goods company with a portfolio spanning laundry, cat litter, oral care, deodorant, and nasal care under iconic brands like Arm & Hammer, OxiClean, and Batiste. As a market leader in the household and personal products industry, the company differentiates itself through a strong portfolio of value-oriented and premium brands that command significant market share in their categories. The current investor narrative centers on the company's ability to sustain mid-single-digit organic growth through product innovation and strategic acquisitions, such as the recent addition of Touchland hand sanitizer, while navigating input cost inflation and shifting consumer spending patterns. Debate remains around margin expansion potential and the impact of private label competition in a softening macroeconomic environment.…
CHD
Church & Dwight
$97.16
CHD 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Church & Dwight's 12-month outlook, with a consensus price target around $126.31 and implied upside of +30.0% versus the current price.
Average Target
$126.31
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$78 - $126
Analyst target range
Insufficient analyst coverage available. Only one analyst provides estimates, with an average EPS estimate of $4.78 for the current fiscal year, ranging from $4.73 to $4.86, and revenue estimates averaging $7.22 billion. The limited coverage suggests Church & Dwight is a mid-cap stock with moderate institutional interest, which can lead to less efficient price discovery and higher volatility around earnings announcements. The single analyst's estimates imply a forward P/E of 20.2x based on the current price, which is below the trailing multiple, indicating expectations of earnings growth. However, the lack of a consensus target price and buy/sell distribution means investors cannot rely on a broad analyst view for sentiment. The wide range in EPS estimates ($4.73–$4.86) reflects some uncertainty about the company's near-term earnings trajectory, but the tight revenue range ($7.17–$7.33 billion) suggests confidence in top-line stability. Given the sparse coverage, investors should conduct their own fundamental analysis and monitor any new initiations or changes in ratings from major firms.
CHD Technical Analysis
The stock is in a range-bound consolidation pattern over the past year, with a 1-year price change of -2.76% reflecting a lack of clear directional trend. The current price of $96.36 sits at 81.4% of its 52-week range ($81.33–$106.04), indicating it is closer to the upper end but not at new highs, suggesting a neutral-to-bullish posture without overextension. The 52-week low of $81.33 and high of $106.04 define a broad trading band, and the stock's beta of 0.467 implies it is significantly less volatile than the market, making it a defensive holding. Short-term momentum shows a 1-month decline of -1.86% and a 3-month gain of +0.99%, contrasting with the 1-year decline, signaling a potential short-term recovery attempt that has yet to confirm a trend reversal. The 1-month relative strength versus SPY is -5.93%, indicating underperformance, while the 6-month relative strength is +3.56%, suggesting a recent improvement in relative momentum. The 52-week high of $106.04 acts as key resistance; a breakout above this level would signal a resumption of the longer-term uptrend, while a breakdown below the 52-week low of $81.33 could indicate a bearish shift. With a beta of 0.467, the stock is about 53% less volatile than the S&P 500, making it a lower-risk holding suitable for conservative portfolios.
Beta
0.47
0.47x market volatility
Max Drawdown
-17.9%
Largest decline past year
52-Week Range
$81-$106
Price range past year
Annual Return
-0.9%
Cumulative gain past year
| Period | CHD Return | S&P 500 |
|---|---|---|
| 1m | -0.4% | +1.0% |
| 3m | +1.7% | +7.9% |
| 6m | +7.8% | +8.5% |
| 1y | -0.9% | +20.1% |
| ytd | +17.6% | +9.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CHD Fundamental Analysis
Revenue growth has been steady but decelerating, with the most recent quarterly revenue of $1.644 billion in Q4 2025 representing a YoY increase of 3.93%, down from 5.4% growth in Q3 2025 and 7.4% in Q2 2025. The trailing twelve-month revenue trend shows a gradual slowdown from 5.5% in early 2025 to the current 3.9%, driven by moderating volume growth and a tougher comparison base. The company's revenue is heavily concentrated in the U.S. (80% of sales), and the Specialty Products Division contributed $73.2 million, a small but high-margin segment. The deceleration raises questions about the sustainability of organic growth, though acquisitions like Touchland provide incremental upside. Profitability remains solid, with net income of $143.5 million in Q4 2025 and a gross margin of 45.85%, which has expanded from 44.75% in Q4 2024, reflecting improved cost management and pricing power. Operating margin of 17.37% is healthy for the household products industry, though it has compressed from 20.13% in Q1 2025 due to higher SG&A spending. The net margin of 8.73% in Q4 2025 is below the 15.0% reported in Q1 2025, indicating some earnings pressure from increased interest expense and tax rates. The balance sheet is conservatively leveraged, with a debt-to-equity ratio of 0.55 and a current ratio of 1.07, indicating adequate liquidity. Free cash flow generation is robust, with TTM free cash flow of $1.093 billion, translating to a free cash flow yield of approximately 5.4% based on the current market cap. ROE of 18.4% is strong, reflecting efficient capital allocation, though the payout ratio of 39% leaves room for dividend growth or reinvestment. The company's ability to generate consistent cash flow supports its investment-grade credit profile and funds both organic initiatives and bolt-on acquisitions.
Quarterly Revenue
$1.6B
2025-12
Revenue YoY Growth
+3.93%
YoY Comparison
Gross Margin
45.85%
Latest Quarter
Free Cash Flow
$1.1B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CHD Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 27.58x, while the forward P/E is 23.63x, implying the market expects earnings growth of about 16.7% over the next year. The gap between trailing and forward multiples suggests optimism about near-term earnings acceleration, likely driven by margin recovery and cost savings. Compared to the household & personal products industry average P/E of approximately 22x (based on sector data), Church & Dwight trades at a 25% premium, reflecting its strong brand portfolio, consistent growth, and defensive characteristics. The premium is partially justified by its superior gross margin of 44.7% versus the industry average of ~40%, but the forward PEG ratio of 1.01x suggests the stock is fairly valued relative to its expected earnings growth rate. Historically, the stock's trailing P/E has ranged from 22x to 40x over the past five years, with the current 27.6x near the midpoint of that range. This is below the 5-year average of 30x, indicating that the stock is not excessively expensive by its own history, but also not at a deep discount. The current valuation implies the market is pricing in a moderate growth outlook without excessive optimism, leaving room for upside if the company delivers above-consensus results.
PE
27.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range -85x~40x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.0x
Enterprise Value Multiple

